Prediction Model of Serum Lithium Concentrations

Kazunari Yoshida, Hiroyuki Uchida, Takefumi Suzuki, Masahiro Watanabe, Nariyasu Yoshino, Hitoshi Houchi, Masaru Mimura, Noriyasu Fukuoka

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction Therapeutic drug monitoring is necessary for lithium, but clinical application of several prediction strategies is still limited because of insufficient predictive accuracy. We herein proposed a suitable model, using creatinine clearance (CLcr)-based lithium clearance (Li-CL). Methods Patients receiving lithium provided the following information: serum lithium and creatinine concentrations, time of blood draw, dosing regimen, concomitant medications, and demographics. Li-CL was calculated as a daily dose per trough concentration for each subject, and the mean of Li-CL/CLcr was used to estimate Li-CL for another 30 subjects. Serum lithium concentrations at the time of sampling were estimated by 1-compartment model with Li-CL, fixed distribution volume (0.79 L/kg), and absorption rate (1.5/hour) in the 30 subjects. Results One hundred thirty-one samples from 82 subjects (44 men; mean±standard deviation age: 51.4±16.0 years; body weight: 64.6±13.8 kg; serum creatinine: 0.78±0.20 mg/dL; dose of lithium: 680.2±289.1 mg/day) were used to develop the pharmacokinetic model. The mean±standard deviation (95% confidence interval) of absolute error was 0.13±0.09 (0.10–0.16) mEq/L. Discussion Serum concentrations of lithium can be predicted from oral dosage with high precision, using our prediction model.

Original languageEnglish
JournalPharmacopsychiatry
DOIs
Publication statusAccepted/In press - 2017 Jul 13

Fingerprint

Lithium
Serum
Creatinine
Drug Monitoring
Pharmacokinetics
Body Weight
Demography
Confidence Intervals

Keywords

  • lithium
  • prediction
  • therapeutic drug monitoring

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Yoshida, K., Uchida, H., Suzuki, T., Watanabe, M., Yoshino, N., Houchi, H., ... Fukuoka, N. (Accepted/In press). Prediction Model of Serum Lithium Concentrations. Pharmacopsychiatry. https://doi.org/10.1055/s-0043-116855

Prediction Model of Serum Lithium Concentrations. / Yoshida, Kazunari; Uchida, Hiroyuki; Suzuki, Takefumi; Watanabe, Masahiro; Yoshino, Nariyasu; Houchi, Hitoshi; Mimura, Masaru; Fukuoka, Noriyasu.

In: Pharmacopsychiatry, 13.07.2017.

Research output: Contribution to journalArticle

Yoshida, Kazunari ; Uchida, Hiroyuki ; Suzuki, Takefumi ; Watanabe, Masahiro ; Yoshino, Nariyasu ; Houchi, Hitoshi ; Mimura, Masaru ; Fukuoka, Noriyasu. / Prediction Model of Serum Lithium Concentrations. In: Pharmacopsychiatry. 2017.
@article{7a273e182adf47d19f0f3d997635acc0,
title = "Prediction Model of Serum Lithium Concentrations",
abstract = "Introduction Therapeutic drug monitoring is necessary for lithium, but clinical application of several prediction strategies is still limited because of insufficient predictive accuracy. We herein proposed a suitable model, using creatinine clearance (CLcr)-based lithium clearance (Li-CL). Methods Patients receiving lithium provided the following information: serum lithium and creatinine concentrations, time of blood draw, dosing regimen, concomitant medications, and demographics. Li-CL was calculated as a daily dose per trough concentration for each subject, and the mean of Li-CL/CLcr was used to estimate Li-CL for another 30 subjects. Serum lithium concentrations at the time of sampling were estimated by 1-compartment model with Li-CL, fixed distribution volume (0.79 L/kg), and absorption rate (1.5/hour) in the 30 subjects. Results One hundred thirty-one samples from 82 subjects (44 men; mean±standard deviation age: 51.4±16.0 years; body weight: 64.6±13.8 kg; serum creatinine: 0.78±0.20 mg/dL; dose of lithium: 680.2±289.1 mg/day) were used to develop the pharmacokinetic model. The mean±standard deviation (95{\%} confidence interval) of absolute error was 0.13±0.09 (0.10–0.16) mEq/L. Discussion Serum concentrations of lithium can be predicted from oral dosage with high precision, using our prediction model.",
keywords = "lithium, prediction, therapeutic drug monitoring",
author = "Kazunari Yoshida and Hiroyuki Uchida and Takefumi Suzuki and Masahiro Watanabe and Nariyasu Yoshino and Hitoshi Houchi and Masaru Mimura and Noriyasu Fukuoka",
year = "2017",
month = "7",
day = "13",
doi = "10.1055/s-0043-116855",
language = "English",
journal = "Pharmacopsychiatry",
issn = "0176-3679",
publisher = "Georg Thieme Verlag",

}

TY - JOUR

T1 - Prediction Model of Serum Lithium Concentrations

AU - Yoshida, Kazunari

AU - Uchida, Hiroyuki

AU - Suzuki, Takefumi

AU - Watanabe, Masahiro

AU - Yoshino, Nariyasu

AU - Houchi, Hitoshi

AU - Mimura, Masaru

AU - Fukuoka, Noriyasu

PY - 2017/7/13

Y1 - 2017/7/13

N2 - Introduction Therapeutic drug monitoring is necessary for lithium, but clinical application of several prediction strategies is still limited because of insufficient predictive accuracy. We herein proposed a suitable model, using creatinine clearance (CLcr)-based lithium clearance (Li-CL). Methods Patients receiving lithium provided the following information: serum lithium and creatinine concentrations, time of blood draw, dosing regimen, concomitant medications, and demographics. Li-CL was calculated as a daily dose per trough concentration for each subject, and the mean of Li-CL/CLcr was used to estimate Li-CL for another 30 subjects. Serum lithium concentrations at the time of sampling were estimated by 1-compartment model with Li-CL, fixed distribution volume (0.79 L/kg), and absorption rate (1.5/hour) in the 30 subjects. Results One hundred thirty-one samples from 82 subjects (44 men; mean±standard deviation age: 51.4±16.0 years; body weight: 64.6±13.8 kg; serum creatinine: 0.78±0.20 mg/dL; dose of lithium: 680.2±289.1 mg/day) were used to develop the pharmacokinetic model. The mean±standard deviation (95% confidence interval) of absolute error was 0.13±0.09 (0.10–0.16) mEq/L. Discussion Serum concentrations of lithium can be predicted from oral dosage with high precision, using our prediction model.

AB - Introduction Therapeutic drug monitoring is necessary for lithium, but clinical application of several prediction strategies is still limited because of insufficient predictive accuracy. We herein proposed a suitable model, using creatinine clearance (CLcr)-based lithium clearance (Li-CL). Methods Patients receiving lithium provided the following information: serum lithium and creatinine concentrations, time of blood draw, dosing regimen, concomitant medications, and demographics. Li-CL was calculated as a daily dose per trough concentration for each subject, and the mean of Li-CL/CLcr was used to estimate Li-CL for another 30 subjects. Serum lithium concentrations at the time of sampling were estimated by 1-compartment model with Li-CL, fixed distribution volume (0.79 L/kg), and absorption rate (1.5/hour) in the 30 subjects. Results One hundred thirty-one samples from 82 subjects (44 men; mean±standard deviation age: 51.4±16.0 years; body weight: 64.6±13.8 kg; serum creatinine: 0.78±0.20 mg/dL; dose of lithium: 680.2±289.1 mg/day) were used to develop the pharmacokinetic model. The mean±standard deviation (95% confidence interval) of absolute error was 0.13±0.09 (0.10–0.16) mEq/L. Discussion Serum concentrations of lithium can be predicted from oral dosage with high precision, using our prediction model.

KW - lithium

KW - prediction

KW - therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=85027061576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027061576&partnerID=8YFLogxK

U2 - 10.1055/s-0043-116855

DO - 10.1055/s-0043-116855

M3 - Article

C2 - 28768341

AN - SCOPUS:85027061576

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

SN - 0176-3679

ER -